SB 328437
a CC chemokine receptor-3 antagonist that inhibits binding of eotaxin and monocyte chemotactic protein-4 to eosinophils; structure in first source
Also Known As:
SB-328437; methyl 2-naphthoylamino-3-(4-nitrophenyl)propionate
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Apostolopoulos, V:
1 article
(11/2018)
|
2. | Bornstein, J C:
1 article
(11/2018)
|
3. | Filippone, R T:
1 article
(11/2018)
|
4. | Jovanovska, V:
1 article
(11/2018)
|
5. | Nurgali, K:
1 article
(11/2018)
|
6. | Robinson, A M:
1 article
(11/2018)
|
7. | Stavely, R:
1 article
(11/2018)
|
8. | Hiroi, Takachika:
1 article
(08/2007)
|
9. | Kaminuma, Osamu:
1 article
(08/2007)
|
10. | Kitamura, Fujiko:
1 article
(08/2007)
|
Related Diseases
Related Drugs and Biologics